» Articles » PMID: 34966372

The Regulatory Network of Cyclic GMP-AMP Synthase-Stimulator of Interferon Genes Pathway in Viral Evasion

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2021 Dec 30
PMID 34966372
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Virus infection has been consistently threatening public health. The cyclic GMP-AMP synthase (cGAS)-Stimulator of Interferon Genes (STING) pathway is a critical defender to sense various pathogens and trigger innate immunity of mammalian cells. cGAS recognizes the pathogenic DNA in the cytosol and then synthesizes 2'3'-cyclic GMP-AMP (2'3'cGAMP). As the second messenger, cGAMP activates STING and induces the following cascade to produce type I interferon (IFN-I) to protect against infections. However, viruses have evolved numerous strategies to hinder the cGAS-STING signal transduction, promoting their immune evasion. Here we outline the current status of the viral evasion mechanism underlying the regulation of the cGAS-STING pathway, focusing on how post-transcriptional modifications, viral proteins, and non-coding RNAs involve innate immunity during viral infection, attempting to inspire new targets discovery and uncover potential clinical antiviral treatments.

Citing Articles

CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling.

Pan M, Hu T, Lyu J, Yin Y, Sun J, Wang Q Autophagy. 2023; 20(2):311-328.

PMID: 37723657 PMC: 10813568. DOI: 10.1080/15548627.2023.2256135.


An Update on Toll-like Receptor 2, Its Function and Dimerization in Pro- and Anti-Inflammatory Processes.

Colleselli K, Stierschneider A, Wiesner C Int J Mol Sci. 2023; 24(15).

PMID: 37569837 PMC: 10419760. DOI: 10.3390/ijms241512464.


Statins in Cancer Prevention and Therapy.

Ricco N, Kron S Cancers (Basel). 2023; 15(15).

PMID: 37568764 PMC: 10417177. DOI: 10.3390/cancers15153948.


Immunomodulatory Role of Interferons in Viral and Bacterial Infections.

Mertowska P, Smolak K, Mertowski S, Grywalska E Int J Mol Sci. 2023; 24(12).

PMID: 37373262 PMC: 10298684. DOI: 10.3390/ijms241210115.


Post-Translational Modifications of STING: A Potential Therapeutic Target.

Kang J, Wu J, Liu Q, Wu X, Zhao Y, Ren J Front Immunol. 2022; 13:888147.

PMID: 35603197 PMC: 9120648. DOI: 10.3389/fimmu.2022.888147.

References
1.
Birgisdottir A, Lamark T, Johansen T . The LIR motif - crucial for selective autophagy. J Cell Sci. 2013; 126(Pt 15):3237-47. DOI: 10.1242/jcs.126128. View

2.
Schwanke H, Stempel M, Brinkmann M . Of Keeping and Tipping the Balance: Host Regulation and Viral Modulation of IRF3-Dependent Expression. Viruses. 2020; 12(7). PMC: 7411613. DOI: 10.3390/v12070733. View

3.
Bodda C, Reinert L, Fruhwurth S, Richardo T, Sun C, Zhang B . HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection. J Exp Med. 2020; 217(7). PMC: 7336311. DOI: 10.1084/jem.20191422. View

4.
Berthelot J, Liote F, Maugars Y, Sibilia J . Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?. Front Immunol. 2020; 11:607069. PMC: 7736628. DOI: 10.3389/fimmu.2020.607069. View

5.
Hilgenfeld R . From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J. 2014; 281(18):4085-96. PMC: 7163996. DOI: 10.1111/febs.12936. View